{"id":168512,"date":"2023-02-03T12:14:30","date_gmt":"2023-02-03T09:14:30","guid":{"rendered":"https:\/\/www.enerjigazetesi.ist\/?p=168512"},"modified":"2023-02-03T12:17:06","modified_gmt":"2023-02-03T09:17:06","slug":"saglik-erkeklerde-en-cok-akciger-kadinlarda-meme-kanseri-goruluyor","status":"publish","type":"post","link":"https:\/\/www.enerjigazetesi.ist\/en\/saglik-erkeklerde-en-cok-akciger-kadinlarda-meme-kanseri-goruluyor\/","title":{"rendered":"(Turkish) Sa\u011fl\u0131k: Erkeklerde En \u00c7ok Akci\u011fer, Kad\u0131nlarda Meme Kanseri G\u00f6r\u00fcl\u00fcyor"},"content":{"rendered":"<p class=\"qtranxs-available-languages-message qtranxs-available-languages-message-en\">Sorry, this entry is only available in <a href=\"https:\/\/www.enerjigazetesi.ist\/tr\/wp-json\/wp\/v2\/posts\/168512\" class=\"qtranxs-available-language-link qtranxs-available-language-link-tr\" title=\"Turkish\">Turkish<\/a>. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.<\/p><p><\/p>\n<h2>Her y\u0131l g\u00f6r\u00fclen 19 milyon yeni kanser vakas\u0131n\u0131n % 30-50&#8217;sinin \u00f6nlenebilir oldu\u011funu, kanserle m\u00fccadelede en \u00f6nemli g\u00fcc\u00fcn erken te\u015fhis oldu\u011funun alt\u0131n\u0131 \u00e7izen T\u00fcrk Kanser Ara\u015ft\u0131rma ve Sava\u015f Kurumu Derne\u011fi Genel Ba\u015fkan\u0131 Prof. Dr. Tezer Kutluk, 04 \u015eubat D\u00fcnya Kanser G\u00fcn\u00fc vesilesiyle \u00f6nemli bilgiler payla\u015ft\u0131.<\/h2>\n<p><strong>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO) 2020<\/strong> verilerine g\u00f6re T\u00fcrkiye&#8217;de <strong>233.000 vaka tahmin edildi\u011fini<\/strong>, bunun 2040 y\u0131l\u0131nda her y\u0131l i\u00e7in<strong> 392 bine \u00e7\u0131kaca\u011f\u0131n\u0131<\/strong> \u00f6ngermektedir. T\u00fcrkiye&#8217;de kanser \u00f6l\u00fcmleri <strong>2020 y\u0131l\u0131<\/strong> i\u00e7in <img loading=\"lazy\" class=\"alignright wp-image-168515\" src=\"https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2023\/02\/Prof.-Dr.-Tezer-Kutluk.jpg\" alt=\"\" width=\"320\" height=\"344\" srcset=\"https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2023\/02\/Prof.-Dr.-Tezer-Kutluk.jpg 366w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2023\/02\/Prof.-Dr.-Tezer-Kutluk-279x300.jpg 279w, https:\/\/www.enerjigazetesi.ist\/wp-content\/uploads\/2023\/02\/Prof.-Dr.-Tezer-Kutluk-46x50.jpg 46w\" sizes=\"(max-width: 320px) 100vw, 320px\" \/><strong>126 bin<\/strong> civar\u0131nda olup, <strong>2040 y\u0131l\u0131<\/strong>nda bu rakam\u0131n <strong>233.000&#8217;e<\/strong> \u00e7\u0131kmas\u0131 \u00f6ng\u00f6r\u00fclmektedir.<\/p>\n<h3><strong>Erkeklerde en \u00e7ok akci\u011fer, kad\u0131nlarda meme kanseri g\u00f6r\u00fcl\u00fcyor<\/strong><\/h3>\n<p><strong>T\u00fcrk Kanser Ara\u015ft\u0131rma ve Sava\u015f Kurumu Derne\u011fi Genel Ba\u015fkan\u0131 Prof. Dr. Tezer Kutluk<\/strong>: \u201cSa\u011fl\u0131k Bakanl\u0131\u011f\u0131&#8217;n\u0131n 2018 y\u0131l\u0131 verilerine g\u00f6re T\u00fcrkiye&#8217;de ilk be\u015f s\u0131ray\u0131 <em>erkeklerde<\/em> <strong>akci\u011fer\/solunum yollar\u0131, prostat, kal\u0131n barsak, mesane, mide kanseri<\/strong>; <em>kad\u0131nlarda<\/em> <strong>meme, tiroid, kal\u0131n barsak, uterus, akci\u011fer\/solunum yollar\u0131<\/strong> almaktad\u0131r. \u00c7ocuklarda ise her iki cins birlikte al\u0131nd\u0131\u011f\u0131nda ilk 5 s\u0131ray\u0131 l\u00f6semi, sinir sistemi t\u00fcm\u00f6rleri, lenfomalar, n\u00f6roblastoma ve yumu\u015fak doku sarkomlar\u0131 olu\u015fturmaktad\u0131r. Ayn\u0131 s\u0131ralama D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc&#8217;n\u00fcn 2020 y\u0131l\u0131 verilerine g\u00f6re de bildirilmektedir\u201d dedi.<\/p>\n<h3><strong>Kanser her ya\u015fta g\u00f6r\u00fclen \u0131rk, cins, \u00fclke ayr\u0131m\u0131 g\u00f6zetmeyen bir hastal\u0131kt\u0131r<\/strong><\/h3>\n<p>\u201cYa\u015f gruplar\u0131 hastal\u0131klara g\u00f6re de\u011fi\u015fmekle birlikte, kanser genel olarak 50&#8217;li ya\u015flardan sonra daha s\u0131k g\u00f6r\u00fclmektedir\u201d diyen <strong>Prof. Dr. Tezer Kutluk<\/strong> kanserin her ya\u015fta g\u00f6r\u00fclen, \u0131rk, cins, \u00fclke ayr\u0131m\u0131 g\u00f6zetmeyen bir hastal\u0131k oldu\u011funun alt\u0131n\u0131 \u00e7izdi ve \u00e7ocuklarda daha az g\u00f6r\u00fclmekle birlikte, yeni do\u011fan d\u00f6neminden ergenli\u011fe kadar her d\u00f6nemde kanser g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc belirtti.<\/p>\n<p>Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 2018 y\u0131l\u0131 verilerine g\u00f6re 211.000 ki\u015finin kanser tan\u0131s\u0131 ald\u0131\u011f\u0131n\u0131 ifade eden <strong>Prof. Dr. Tezer Kutluk <\/strong>s\u00f6zlerine \u015funlar\u0131 ekledi: \u201cKanser s\u0131kl\u0131\u011f\u0131 y\u00fcz binde 225 olarak bildirilmi\u015ftir. Baz\u0131 bat\u0131 \u00fclkelerinde g\u00f6re d\u00fc\u015f\u00fck gibi g\u00f6r\u00fcnse de bu durum yanl\u0131\u015f yorumlanmamal\u0131d\u0131r. Beklenen ya\u015fam s\u00fcresinin uzamas\u0131, n\u00fcfus art\u0131\u015f\u0131, ya\u015fam tarz\u0131 gibi nedenlerde T\u00fcrkiye&#8217;de de her ge\u00e7en g\u00fcn kanser say\u0131s\u0131 artmaktad\u0131r. \u00dclkemizde 30.000&#8217;i a\u015fk\u0131n akci\u011fer kanseri g\u00f6r\u00fclmektedir. \u00dclkemizde 0-14 ya\u015f grubunda \u00e7ocuklarda ise her y\u0131l 3.000 civar\u0131nda kanser g\u00f6r\u00fclmektedir.\u201d<\/p>\n<h3><strong>D\u00fcnyada ve T\u00fcrkiye&#8217;de hastal\u0131klar aras\u0131nda kanser ikinci \u00f6l\u00fcm nedeni <\/strong><\/h3>\n<p>Kanser \u00f6l\u00fcmlerinin d\u00fcnyada ve T\u00fcrkiye&#8217;de kalp damar hastal\u0131klar\u0131ndan sonra ikinci s\u0131ray\u0131 ald\u0131\u011f\u0131n\u0131 s\u00f6yleyen <strong>Prof. Dr. Tezer Kutluk: <\/strong>\u201cAncak ikinci s\u0131raya ra\u011fmen kanserden korunma, erken tan\u0131 ve etkin tedavi ile bu \u00f6l\u00fcmlerin 3-5 milyon kadar\u0131n\u0131 k\u0131sa ve orta vadede \u00f6nlemenin m\u00fcmk\u00fcn, her y\u0131l g\u00f6r\u00fclen 19 milyon yeni kanser vakas\u0131n\u0131n y\u00fczde 30-50&#8217;sinin \u00f6nlenebilir oldu\u011funu biliyoruz. B\u00fct\u00fcn bu say\u0131 ve oranlar bize korunma, tarama, erken tan\u0131 ve etkin tedavinin \u00f6nemini hat\u0131rlat\u0131yor\u201d dedi.<\/p>\n<p>\u0130yile\u015fme oranlar\u0131n\u0131n d\u00fcnya ortalamas\u0131n\u0131n y\u00fczde 42 oldu\u011funu ifade eden <strong>Prof. Dr. Tezer Kutluk<\/strong>, bu oranlar\u0131n \u00fcst gelir kategorisindeki \u00fclkelerde y\u00fczde 55 iken, d\u00fc\u015f\u00fck gelir kategorisindeki \u00fclkelerde y\u00fczde 20&#8217;lerin alt\u0131nda d\u00fc\u015ft\u00fc\u011f\u00fcne dikkat \u00e7ekti.<\/p>\n<p><strong>Prof. Dr. Tezer Kutluk<\/strong>: \u201c\u00dcst gelir kategorisindeki \u00fclkelerde son 20 y\u0131lda kansere ba\u011fl\u0131 \u00f6l\u00fcmlerin azalma e\u011filiminde oldu\u011funu biliyoruz, ancak COVID-19 s\u00fcreci sonras\u0131nda da taramalar\u0131n aksamas\u0131, hizmete eri\u015fimde sorunlar ve tan\u0131da gecikmeler sebepli tekrar bir art\u0131\u015f beklenmektedir. Pandemi \u00f6ncesinde y\u0131ll\u0131k 7 milyon olan tarama say\u0131lar\u0131 2020 ve 2021&#8217;de 3.5 milyona d\u00fc\u015fm\u00fc\u015f olup sonra tekrar artmaya ba\u015flam\u0131\u015ft\u0131r. Bireylerin taramalar\u0131n\u0131 ihmal etmemeleri \u00f6nemlidir\u201d dedi.<\/p>\n<h3><strong>Bu belirtilere dikkat <\/strong><\/h3>\n<p>Kanser taramalar\u0131n\u0131n \u00f6zellikle 3 kanser t\u00fcr\u00fcnde toplum tabanl\u0131 olarak tavsiye edilmekte oldu\u011funu dile getiren <strong>Prof. Dr. Tezer Kutluk:<\/strong> <em>\u201cServiks kanserinde (rahim a\u011fz\u0131) cinsellik ba\u015flad\u0131ktan sonra, kal\u0131n barsak kanserinde 50&#8217;li ya\u015flardan sonra, meme kanserinde 40&#8217;l\u0131 ya\u015flardan sonra taramalar\u0131n\u0131 yapt\u0131rmal\u0131d\u0131r. Yak\u0131n y\u0131llarda d\u00fc\u015f\u00fck doz bilgisayarl\u0131 tomografi ile akci\u011fer kanseri taramalar\u0131 baz\u0131 \u00fclkelerde uygulanmaya ba\u015flanm\u0131\u015ft\u0131r\u201d<\/em> dedi.<\/p>\n<p><strong>Prof. Dr. Kutluk<\/strong>, kanser belirtilerini <span style=\"text-decoration: underline;\">\u015f\u00f6yle s\u0131ralad\u0131:<\/span><\/p>\n<p>&#8211; Genellikle a\u011fr\u0131s\u0131z, boyutlar\u0131 b\u00fcy\u00fcyebilen ola\u011fand\u0131\u015f\u0131 \u015fi\u015flikler ve\/ya kitleler<\/p>\n<p>&#8211; Uzun s\u00fcren, kal\u0131c\u0131 \u00f6ks\u00fcr\u00fck, nefes darl\u0131\u011f\u0131, yutma g\u00fc\u00e7l\u00fc\u011f\u00fc<\/p>\n<p>&#8211; Barsak al\u0131\u015fkanl\u0131klar\u0131nda de\u011fi\u015fiklikler, (kab\u0131zl\u0131k, kanama\u2026)<\/p>\n<p>&#8211; \u0130drar yapma al\u0131\u015fkanl\u0131klar\u0131nda de\u011fi\u015fiklikler<\/p>\n<p>&#8211; Kanamalar: vajen, makat, \u00f6ks\u00fcr\u00fck<\/p>\n<p>&#8211; K\u0131sa s\u00fcrede a\u00e7\u0131klanamayan kilo kayb\u0131<\/p>\n<p>&#8211; Tu\u0308kenmi\u015flik, as\u0327\u0131r\u0131 yorgunluk ve s\u0327iddetli enerji eksiklig\u0306i<\/p>\n<p>&#8211; Deride yeni ben c\u0327\u0131kmas\u0131 ya da var olan benlerin bu\u0308yu\u0308klu\u0308g\u0306u\u0308, s\u0327ekli veya renginde deg\u0306is\u0327iklik olmas\u0131, s\u0131z\u0131nt\u0131, kabuklanma, kanama olmas\u0131<\/p>\n<p>&#8211; Ac\u0327\u0131klanamayan veya devam eden ag\u0306r\u0131 veya gelen-giden ag\u0306r\u0131<\/p>\n<p>&#8211; Meme bu\u0308yu\u0308klu\u0308g\u0306u\u0308 s\u0327eklinde beklenmedik deg\u0306is\u0327iklikler, derideki deg\u0306is\u0327iklikler ve ag\u0306r\u0131<\/p>\n<p>&#8211; Vu\u0308cutta iyiles\u0327meyen yaralar, ag\u0306\u0131z u\u0308lserleri<\/p>\n<p>&#8211; Midede kal\u0131c\u0131 veya ag\u0306r\u0131l\u0131 yanma ve haz\u0131ms\u0131zl\u0131k<\/p>\n<p>&#8211; Ag\u0306\u0131r, s\u0131r\u0131ls\u0131klam gece terlemeleri<\/p>\n<p>Bu belirti ve bulgular mutlaka kanser anlam\u0131na gelmez ama varsa acilen doktora ba\u015fvurmal\u0131s\u0131n\u0131z diyen <strong>Prof. Dr. Tezer Kutluk<\/strong>, kanserden korunmak i\u00e7in t\u00fct\u00fcn ve alkol kullan\u0131lmamas\u0131, beslenmeye dikkat edilmesi, fiziksel aktivite yap\u0131lmas\u0131, kilo fazlal\u0131\u011f\u0131 ve \u015fi\u015fmanl\u0131ktan ka\u00e7\u0131n\u0131lmas\u0131, ideal kilonun korunmas\u0131, ultraviyole ve \u00e7evre kirlili\u011finden uzak durulmas\u0131 ve HPV a\u015f\u0131lanmas\u0131 tedbirlerini \u00f6nerdi.<\/p>\n<p><strong>COVID-19 s\u00fcreci sonras\u0131nda tekrar bir art\u0131\u015f beklenmektedir<\/strong><br \/>\n<strong>Prof. Dr. Tezer Kutluk<\/strong>: \u201cBug\u00fcn bilinen tedavi y\u00f6ntemleri ile tedavi ba\u015far\u0131lar\u0131 eri\u015fkin kanserlerin toplam\u0131nda y\u00fczde 70&#8217;lere dayanm\u0131\u015ft\u0131r. Ancak hedefe y\u00f6nelik yeni tedavi y\u00f6ntemleri bu s\u0131n\u0131r\u0131 zorlamaktad\u0131r. \u00d6te yandan d\u00fcnya genelinde molek\u00fcler tan\u0131ya ve yeni ila\u00e7lara eri\u015fim de sorunlar oldu\u011fu bilinmektedir. Bu modern tan\u0131, uygun cerrahiye eri\u015fim desteklenmelidir. Kanser sa\u011fl\u0131k hizmetlerinde e\u015fitsizliklerin giderilmesi \u00f6nemlidir. Kanser \u00f6l\u00fcmlerinin y\u00fczde 70&#8217;i d\u00fc\u015f\u00fck ve orta gelir d\u00fczeyindeki \u00fclkelerdedir. Y\u00fcksek gelirli \u00fclkelerde tedavi hizmetlerine eri\u015fim y\u00fczde 90 olmas\u0131na kar\u015f\u0131n d\u00fc\u015f\u00fck gelirli \u00fclkelerde bu oran y\u00fczde 30&#8217;un alt\u0131ndad\u0131r. Hizmete eri\u015fimde genel sa\u011fl\u0131k sigortas\u0131 kapsam\u0131nda kanser hizmetleri, tan\u0131 ve tedaviye eri\u015fim kritiktir. Molek\u00fcler tan\u0131 y\u00f6ntemlerine eri\u015fim d\u00fcnyada ve \u00fclkemizde rasyonel planlamalara dahil edilmelidir. \u00dclke politikalar\u0131nda, kanser kontrol plan\u0131 da dikkate al\u0131nmal\u0131d\u0131r.<br \/>\nCOVID-19 s\u00fcrecinde, taramalar\u0131n aksamas\u0131, hizmete eri\u015fimde sorunlar ve tan\u0131da gecikmeler nedeniyle; kanserde korunmadan tedaviye t\u00fcm a\u015famalarda aksaman\u0131n olumsuz etkileri g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131d\u0131r\u201d dedi.<\/p>","protected":false},"excerpt":{"rendered":"<p>Sorry, this entry is only available in Turkish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Her y\u0131l g\u00f6r\u00fclen 19 milyon yeni kanser vakas\u0131n\u0131n % 30-50&#8217;sinin \u00f6nlenebilir oldu\u011funu, kanserle m\u00fccadelede en \u00f6nemli g\u00fcc\u00fcn erken te\u015fhis oldu\u011funun alt\u0131n\u0131 \u00e7izen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":168516,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[53],"tags":[107549,107550,107548],"views":53,"_links":{"self":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/168512"}],"collection":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/comments?post=168512"}],"version-history":[{"count":0,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/168512\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media\/168516"}],"wp:attachment":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media?parent=168512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/categories?post=168512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/tags?post=168512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}